Crestline Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $7.46M | Buy |
|
|||||
|
2024
Q3 | $4.69M | Buy |
|
|||||
|
2024
Q2 | $3.16M | Buy |
|
|||||
|
2024
Q1 | $2.91M | Buy |
|
|||||
|
2023
Q4 | $2.67M | Buy |
|
|||||
|
2023
Q3 | $1.74M | Buy |
|
|||||
|
2023
Q2 | $1.42M | Buy |
|
|||||
|
2023
Q1 | $1.09M | Sell |
|
|||||
|
2022
Q4 | $1.62M | Sell |
|
|||||
|
2022
Q3 | $1.12M | Buy |
|
|||||
|
2022
Q2 | $1.03M | Buy |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|